World Maternal Antifibrinolytic Trial-2
Phase 3
Recruiting
- Conditions
- Pregnancy and Childbirth
- Registration Number
- PACTR201909735842379
- Lead Sponsor
- ondon School of Hygiene and Tropical Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 10000
Inclusion Criteria
Women with moderate or severe anaemia (haemoglobin level <100 g/L or packed cell volume <30%),
and who have given birth vaginally
and for who the responsible clinician is substantially uncertain whether to use TXA.
Exclusion Criteria
Women who are not legally adult (<18 years) and permission not provided by a guardian.
Women with a known allergy to TXA or its excipients.
Women who develop PPH before umbilical cord is clamped/cut.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method